Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol

European Journal of Emergency Medicine

Volumn 15, Issue 1, 2008, Pages 9-15

  Hamilton, Andrew J ^a   Swales, Leslie A ^a   Neill, Johanne ^a   Murphy, John C ^a   Darragh, Karen M ^a   Rocke, Laurence G ^a   Adgey, Jennifer ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Brain natriuretic peptide; Chest pain; Point of care biomarkers; Risk stratification

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; MYOGLOBIN; TROPONIN;

ACUTE HEART INFARCTION; ADULT; ANALYTIC METHOD; ARTICLE; ASBESTOSIS; CARCINOMA; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL LABORATORY; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; STATISTICS; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHEST PAIN; EMERGENCY NURSING; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NURSES; POINT-OF-CARE SYSTEMS; RETROSPECTIVE STUDIES; ROC CURVE; TRIAGE; TROPONIN I; TROPONIN T;

EID: 37849034544     PISSN: 09699546     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e3282aa4045     Document Type: Article

References (15)

1. Clancy M. Chest Pain Units. BMJ 2002; 325:116-117.
2. Capewell S. The continuing rise in emergency admissions. BMJ 1996; 312:991-992.
3. Dougan JP, Mathew TP, Riddell JW, Spence MS, McGlinchey PG, Nesbitt GS, et al. Suspected angina pectoris: a rapid-access chest pain clinic. Q J Med 2001; 94:679-686.
4. Antman EM, Cohen M, Bernink PJLM, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI. JAMA 2000; 284:835-842.
5. Dunn F, Hughes D, Rocke LG, McNicholl BP. Are chest pain observation units essential for rapid and effective emergency care in the UK? Emerg Med J 2006; 23:487.
6. Muir AR, Neill J, Darragh K, Dougan J, Patterson C, Adgey AAJ. Use of N-terminal pro-brain natriuretic peptide as a diagnostic and prognostic marker for ischaemic heart disease in patients presenting to a rapid access chest pain clinic. J Am Coll Cardiol 2006; 47:4,352A.
7. Higgins B, Higgins R, Kelson M, Rutherford P, Shovelton H, Wise F, et al. NICE Guidelines on Chronic Heart Failure, Clinical Guideline 5, July 2003, p. 5. www.nice.org.uk/pdf/CG5NICEguideline.pdf.
8. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-pro BNP in clinical routine. Heart 2006; 92:843-849.
9. Galasko GIW, Lahiri A, Barnes SC, Collinson P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005; 26:2269-2276.
10. Struthers AD and Davies J. β-type natriuretic peptide: a simple new test to identify coronary artery disease? Q J Med 2005; 98:765-769.
11. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omlan T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663.
12. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. BNP and ischaemia in patients with stable coronary disease: data from the heart and soul study. Circulation 2003; 108:2987-2992.
13. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, DiBattiste PM, Morrow DA, et al. Association of elevated β-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44:564-568.
14. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005; 26:234-240.
15. Bibbins-Domingo K, Gupta R, Na B, Wu AHB, Schiller NB, Whooley MA. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007; 297:169-176.